Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5.37 USD | -2.72% | +3.47% | +42.82% |
15/04 | CorMedix's DefenCath Now Commercially Available For US Inpatient Use | MT |
15/04 | CorMedix Inc. Announces U.S. Inpatient Commercial Availability of DefenCath®? (Taurolidine and Heparin) | CI |
Turnover - Change in analysts' estimates
Earnings Per Share (EPS) - Change in analysts' estimates
EBIT - Change in analysts' estimates
Turnover
Earnings Per Share (EPS)
EBIT
- Stock Market
- Equities
- CRMD Stock
- Revisions CorMedix Inc.